BioSpace News Archive

Press Releases

Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program

October 6, 2025
·
7 min read
Press Releases

Cell and Gene Therapies on the Rise: New Report Reveals Growing Adoption and Persistent Challenges

October 6, 2025
·
3 min read
Press Releases

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

October 6, 2025
·
4 min read
Press Releases

Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer

October 6, 2025
·
8 min read
Press Releases

Optimi Health’s Psilocybin Capsules Selected for Medibank Insurance Program

Australia’s largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSD

October 6, 2025
·
5 min read
Press Releases

Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025

October 6, 2025
·
3 min read
Press Releases

BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial Study of ML-016 in Advanced Cancers with Lung and/or Liver Involvement

October 6, 2025
·
1 min read
Press Releases

Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test

October 6, 2025
·
3 min read
Press Releases

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

October 6, 2025
·
4 min read
Press Releases

Ryoncil® Revenues Increase 66% in Second Quarter Post Launch

October 6, 2025
·
5 min read